Turn Therapeutics Statistics
NASDAQ: TTRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
8.10-0.545 (-6.31%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Turn Therapeutics by the numbers
Turn Therapeutics has a market capitalization of $247.5 million based on 30.57M shares outstanding. With trailing EPS of $-0.43, Turn Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.5% below its 50-day average and 9.9% above its 200-day average.
Average daily trading volume is 119.32K shares, or about $965,879 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TTRX valuation vs. peer median
| Metric | TTRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $247.49M | $258.72M | -4% |
| Avg. volume | 119.32K | 423.72K | -72% |
Peer median across 8 companies: QTTB, LFCR, CAMP, PRLD, ALT, EBS, VCRE, GALT.
Valuation
- Market cap
- $247.49M
- EPS (TTM)
- $-0.43
- Shares outstanding
- 30.57M
Price and trading
- Previous close
- 8.64
- Open
- 8.85
- Day range
- 7.93 – 9.20
- 52-week range
- 2.70 – 16.45
- 52-week change
- +147.55%
- Beta
- —
- Volume
- 82.67K
- Average volume
- 119.32K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 247.49M
- Forward Pe
- -53.97
- Eps
- -0.43
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 16.45
- Week52 Low
- 2.70
- Avg Volume
- 119.32K
- Shares Outstanding
- 30.57M
- Ma50
- 11.32
- Ma200
- 7.37
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -50.79%
- Pct From52w Low
- 199.81%